$255.68
-0.88-0.34%
Last update: Aug 10, 9:10 AM
Jazz Pharmaceuticals PLC
JAZZNASDAQ
Earnings: Q2 2026 Earnings were released on Mon Aug 3rd, after the market close
Conference Call: The most recent conference call started at 4:30 PM, 7 days agoClick to view the webcast
M&A: Actio Biosciences, Inc announced today it will be acquired by Jazz Pharmaceuticals (JAZZ) for $820M
Jazz Pharmaceuticals Ownership & Insider Activity
Jazz Pharmaceuticals (JAZZ) institutional and insider ownership, recent insider transactions and ownership breakdown.
Insiders own 5.8% of shares outstanding. Institutional investors hold 77.2%. Over the past 90 days, insiders made 7 sales worth $5.7M.
Shares Outstanding
62.739M
Shares Float
54.511M
Insider Shares Owned
3.629M
Insider % Owned
5.8%
Institutional Shares Held
50.110M
Institutional % Held
77.2%
Ownership Breakdown
Net Insider Activity by Month
Purchases (90d)
0
Sales (90d)
7
$5.7M total
Net Activity
Net Selling
Net Value (90d)
-$5.7M
